Cathepsin e inhibitor

Cathepsin e inhibitor has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Nov 12, 2026: “Enzyme inhibitor reduced brain inflammation in mice”.

Intervention

1 paper studies it3 findingsUpdated Nov 11, 2026

1 new paper in 30 daysSee all 1 papers on cathepsin e inhibitor

At a glance

The findings reach mice, none yet in people. 1 lab.

None of its findings points the other way.

1 lab

Animals1

What did studies of cathepsin e inhibitor find?

Studies of cathepsin e inhibitor measured 3 outcomes: cognitive function, inflammation and T cell infiltration.

Cognitive function

upin mice1

1 study

Cathepsin e inhibitor improves cognitive function in mice (AD models).
“Pharmacological suppression of peripheral CatE effectively restricted T‐cell infiltration, attenuated neuroinflammation, and restored cognitive function in AD models.”
AnimalsAD modelsbrain-impermeable
Enzyme inhibitor reduced brain inflammation in mice
Alzheimer's & dementia : the journal of the Alzheimer's AssociationNov 11, 2026

Inflammation

downin mice1

1 study

Cathepsin e inhibitor decreases inflammation in mice (AD models).
“Pharmacological suppression of peripheral CatE effectively restricted T‐cell infiltration, attenuated neuroinflammation, and restored cognitive function in AD models.”
AnimalsAD modelsbrain-impermeablebrain
Enzyme inhibitor reduced brain inflammation in mice
Alzheimer's & dementia : the journal of the Alzheimer's AssociationNov 11, 2026

Latest

1 paper in 12 months

Alzheimer's & DementiaNov 12

Enzyme inhibitor reduced brain inflammation in mice

Daily injections for six weeks restricted immune-cell entry into the brain and restored cognitive function in male mice modeling Alzheimer's disease.Daily injections for six weeks restricted immune-cell entry into the brain and restored cognitive function in male mice modeling Alzheimer's disease.

Mouse studyInflammation

Paper